The causative role of MIF in cancer progression was initially linked to its increased expression by a variety of cancer cells, including prostate, colon, hepatocellular, lung, ovarian, in addition to melanoma, glioblastoma and neuroblastoma (2). This evidence concerns the gene MIF and melanoma.